Browsing Category
Medicine
Pfizer: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30-µg booster dose of their Omicron BA.1 Bivalent COVID-19 Vaccine (COMIRNATY® Original/Omicron BA.1 15/15 µg) has been recommended for conditional marketing!-->…
Yale Study Offers Multiple Strategies for Containing Monkeypox
As the number of confirmed monkeypox cases in the United States climbs, the need to contain the virus is clear. But what will it take to bring the outbreak under control?
A new study from the Yale School of Public Health (YSPH) sets…
Pfizer: Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12!-->…
Pfizer: Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced updated efficacy results from a Phase 2/3 trial evaluating a three 3-µg dose series of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of!-->…
Pfizer: Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron!-->…
Pfizer: Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion…
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol),100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed!-->…
Apollo Proton Cancer Centre in India becomes Asia’s First and Exclusive Proton Beam Training…
Chennai : Apollo Proton Cancer Centre (APCC), the first & only Proton Therapy Centre in South Asia & the Middle East, and Ion Beam Applications (IBA), Belgium, signed an agreement to offer proton therapy training and education for…
Pfizer: Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal…
Pfizer Inc. (NYSE:PFE) today announced positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive!-->…
Pfizer: Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare…
Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical company dedicated to the!-->…
Pfizer: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to investigate the efficacy,!-->…